secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silence Therapeutics plc (SLN)
CIK:        0001479615
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001193125-25-149704
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Silence Therapeutics shareholders approve all 13 AGM resolutions, re-elect directors
--------------------------------------------------------------------------------

- All directors re-elected: David Lemus (77.0M for), Tim McInerney (77.0M for), Iain Ross (74.8M for), Craig Tooman (78.2M for).
- Advisory say-on-pay resolution passed with 70.8M for vs 3.1M against.
- PwC ratified as US auditor with 78.3M for; 2024 UK accounts adopted with 78.2M for.
- Shareholders voted 77.7M in favor of annual frequency for advisory say-on-pay votes.
- Special resolution to adopt new articles of association passed with 72.6M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479615/000119312525149704/0001193125-25-149704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479615/000119312525149704/d45471d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-149704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer